125 related articles for article (PubMed ID: 38580527)
1. [Live birth rates after breast cancer among women who desired a child].
Charpentier P; Cavalieri M; Desmoulins I; Coutant C
Bull Cancer; 2024 May; 111(5):463-472. PubMed ID: 38580527
[TBL] [Abstract][Full Text] [Related]
2. Modeling of live-birth rates and cost-effectiveness of oocyte cryopreservation for cancer patients prior to high- and low-risk gonadotoxic chemotherapy.
Lyttle Schumacher B; Grover N; Mesen T; Steiner A; Mersereau J
Hum Reprod; 2017 Oct; 32(10):2049-2055. PubMed ID: 28938728
[TBL] [Abstract][Full Text] [Related]
3. Assisted reproductive technology use and outcomes among women with a history of cancer.
Luke B; Brown MB; Missmer SA; Spector LG; Leach RE; Williams M; Koch L; Smith YR; Stern JE; Ball GD; Schymura MJ
Hum Reprod; 2016 Jan; 31(1):183-9. PubMed ID: 26577302
[TBL] [Abstract][Full Text] [Related]
4. Fertility preservation in female oncology patients: the influence of the type of cancer on ovarian stimulation response.
Alvarez RM; Ramanathan P
Hum Reprod; 2018 Nov; 33(11):2051-2059. PubMed ID: 27370358
[TBL] [Abstract][Full Text] [Related]
5. Live birth rate after female fertility preservation for cancer or haematopoietic stem cell transplantation: a systematic review and meta-analysis of the three main techniques; embryo, oocyte and ovarian tissue cryopreservation.
Fraison E; Huberlant S; Labrune E; Cavalieri M; Montagut M; Brugnon F; Courbiere B
Hum Reprod; 2023 Mar; 38(3):489-502. PubMed ID: 36421038
[TBL] [Abstract][Full Text] [Related]
6. Long term pregnancy outcomes of women with cancer following fertility preservation: A systematic review and meta-analysis.
Xu Z; Ibrahim S; Burdett S; Rydzewska L; Al Wattar BH; Davies MC
Eur J Obstet Gynecol Reprod Biol; 2023 Feb; 281():41-48. PubMed ID: 36535069
[TBL] [Abstract][Full Text] [Related]
7. Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval.
Doyle JO; Richter KS; Lim J; Stillman RJ; Graham JR; Tucker MJ
Fertil Steril; 2016 Feb; 105(2):459-66.e2. PubMed ID: 26604065
[TBL] [Abstract][Full Text] [Related]
8. The number of oocytes associated with maximum cumulative live birth rates per aspiration depends on female age: a population study of 221 221 treatment cycles.
Law YJ; Zhang N; Venetis CA; Chambers GM; Harris K
Hum Reprod; 2019 Sep; 34(9):1778-1787. PubMed ID: 31398253
[TBL] [Abstract][Full Text] [Related]
9. A prospective study of women and girls undergoing fertility preservation due to oncologic and non-oncologic indications in Sweden-Trends in patients' choices and benefit of the chosen methods after long-term follow up.
Rodriguez-Wallberg KA; Marklund A; Lundberg F; Wikander I; Milenkovic M; Anastacio A; Sergouniotis F; Wånggren K; Ekengren J; Lind T; Borgström B
Acta Obstet Gynecol Scand; 2019 May; 98(5):604-615. PubMed ID: 30723910
[TBL] [Abstract][Full Text] [Related]
10. Predicting the likelihood of live birth for elective oocyte cryopreservation: a counseling tool for physicians and patients.
Goldman RH; Racowsky C; Farland LV; Munné S; Ribustello L; Fox JH
Hum Reprod; 2017 Apr; 32(4):853-859. PubMed ID: 28166330
[TBL] [Abstract][Full Text] [Related]
11. Fertility after breast cancer treatment.
Kasum M; Beketić-Orešković L; Peddi PF; Orešković S; Johnson RH
Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():13-8. PubMed ID: 24315568
[TBL] [Abstract][Full Text] [Related]
12. Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.
Abir R; Ben-Aharon I; Garor R; Yaniv I; Ash S; Stemmer SM; Ben-Haroush A; Freud E; Kravarusic D; Sapir O; Fisch B
Hum Reprod; 2016 Apr; 31(4):750-62. PubMed ID: 26848188
[TBL] [Abstract][Full Text] [Related]
13. The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review.
Rodgers RJ; Reid GD; Koch J; Deans R; Ledger WL; Friedlander M; Gilchrist RB; Walters KA; Abbott JA
Hum Reprod; 2017 May; 32(5):1033-1045. PubMed ID: 28333356
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of the ovaries in women with breast cancer undergoing fertility preservation: Alternative versus standard stimulation protocols; the study protocol of the STIM-trial.
Dahhan T; Balkenende EME; Beerendonk CCM; Fleischer K; Stoop D; Bos AME; Lambalk CB; Schats R; van Golde RJT; Schipper I; Louwé LA; Cantineau AEP; Smeenk JMJ; de Bruin JP; Reddy N; Kopeika Y; van der Veen F; van Wely M; Linn SC; Goddijn M
Contemp Clin Trials; 2017 Oct; 61():96-100. PubMed ID: 28710053
[TBL] [Abstract][Full Text] [Related]
15. A 10-year follow-up of reproductive outcomes in women attempting motherhood after elective oocyte cryopreservation.
Loreti S; Darici E; Nekkebroeck J; Drakopoulos P; Van Landuyt L; De Munck N; Tournaye H; De Vos M
Hum Reprod; 2024 Feb; 39(2):355-363. PubMed ID: 38145619
[TBL] [Abstract][Full Text] [Related]
16. National patterns of care and fertility outcomes for reproductive-aged women with endometrial cancer or atypical hyperplasia.
Harrison RF; He W; Fu S; Zhao H; Sun CC; Suidan RS; Woodard TL; Rauh-Hain JA; Westin SN; Giordano SH; Meyer LA
Am J Obstet Gynecol; 2019 Nov; 221(5):474.e1-474.e11. PubMed ID: 31128110
[TBL] [Abstract][Full Text] [Related]
17. Evidence-based outcomes after oocyte cryopreservation for donor oocyte in vitro fertilization and planned oocyte cryopreservation: a guideline.
Practice Committee of the American Society for Reproductive Medicine. Electronic address: asrm@asrm.org
Fertil Steril; 2021 Jul; 116(1):36-47. PubMed ID: 34148587
[TBL] [Abstract][Full Text] [Related]
18. Fertility preservation in patients of childbearing age treated for breast cancer: A nationwide cohort study.
Duraes M; Rathat G; Bringer-Deutsch S; Ranisavljevic N; Brouillet S; Defez-Fougeron C; Duflos C
Breast; 2022 Aug; 64():121-126. PubMed ID: 35661841
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes and utilization from over a decade of planned oocyte cryopreservation.
Leung AQ; Baker K; Vaughan D; Shah JS; Korkidakis A; Ryley DA; Sakkas D; Toth TL
Reprod Biomed Online; 2021 Oct; 43(4):671-679. PubMed ID: 34474973
[TBL] [Abstract][Full Text] [Related]
20. Impact of cancer chemotherapy before ovarian cortex cryopreservation on ovarian tissue transplantation.
Poirot C; Fortin A; Lacorte JM; Akakpo JP; Genestie C; Vernant JP; Brice P; Morice P; Leblanc T; Gabarre J; Delmer A; Badachi Y; Drouineaud V; Gouy S; Chalas C; Egels S; Dhédin N; Touraine P; Dommergues M; Lebègue G; Wolf JP; Capron F; Lefebvre G; Boissel N;
Hum Reprod; 2019 Jun; 34(6):1083-1094. PubMed ID: 31116405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
